100 related articles for article (PubMed ID: 17612839)
1. Overexpression of GRF encapsulated in PLGA microspheres in animal skeletal muscle induces body weight gain.
Zhang YL; Ren XH; Liu SC; Dai JW; Hao LL; Jiang QY
Anim Biotechnol; 2007; 18(3):163-75. PubMed ID: 17612839
[TBL] [Abstract][Full Text] [Related]
2. PLGA microsphere-mediated growth hormone release hormone expression induces intergenerational growth.
Ren XH; Zhang YL; Luo HY; Li HY; Liu SC; Zhang MJ; Ouyang SY; Xi QY; Jiang QY
Anim Biotechnol; 2009; 20(3):124-32. PubMed ID: 19544208
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous expression of growth hormone releasing hormone (GHRH) and hepatitis B surface antigen/somatostatin (HBsAg/SS) fusion genes in a construct in the skeletal muscle enhances rabbit weight gain.
Dai JW; Liu SC; Hao LL; Zhang YL; Zhang Q; Ren XH; Jiang QY
Anim Biotechnol; 2008; 19(2):104-16. PubMed ID: 18432401
[TBL] [Abstract][Full Text] [Related]
4. [The expression of growth hormone release factor gene carried with PLGA microspheres in muscle tissue and its effect on mouse growth].
Ren XH; Zhang YL; Liu SC; Dai JW
Sheng Wu Gong Cheng Xue Bao; 2004 Jul; 20(4):615-8. PubMed ID: 15968999
[TBL] [Abstract][Full Text] [Related]
5. Poly(D,L-lactic-co-glycolic acid) microsphere delivery of adenovirus for vaccination.
Wang D; Molavi O; Lutsiak ME; Elamanchili P; Kwon GS; Samuel J
J Pharm Pharm Sci; 2007; 10(2):217-30. PubMed ID: 17706180
[TBL] [Abstract][Full Text] [Related]
6. Versatility of biodegradable poly(D,L-lactic-co-glycolic acid) microspheres for plasmid DNA delivery.
Díez S; Tros de Ilarduya C
Eur J Pharm Biopharm; 2006 Jun; 63(2):188-97. PubMed ID: 16697172
[TBL] [Abstract][Full Text] [Related]
7. Protein delivery from poly(lactic-co-glycolic acid) biodegradable microspheres: release kinetics and stability issues.
Crotts G; Park TG
J Microencapsul; 1998; 15(6):699-713. PubMed ID: 9818948
[TBL] [Abstract][Full Text] [Related]
8. Preparation and in vitro characterization of vascular endothelial growth factor (VEGF)-loaded poly(D,L-lactic-co-glycolic acid) microspheres using a double emulsion/solvent evaporation technique.
Karal-Yılmaz O; Serhatlı M; Baysal K; Baysal BM
J Microencapsul; 2011; 28(1):46-54. PubMed ID: 21171816
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo evaluations of PLGA microsphere vaccine formulations containing pDNA coexpressing hepatitis B surface antigen and Interleukin-2.
Eratalay A; Coşkun-Ari FF; Oner F; Ozcengīz E
J Microencapsul; 2010; 27(1):48-56. PubMed ID: 19545223
[TBL] [Abstract][Full Text] [Related]
10. Enhanced intracellular uptake and inhibition of NF-kappaB activation by decoy oligonucleotide released from PLGA microspheres.
De Rosa G; Maiuri MC; Ungaro F; De Stefano D; Quaglia F; La Rotonda MI; Carnuccio R
J Gene Med; 2005 Jun; 7(6):771-81. PubMed ID: 15702489
[TBL] [Abstract][Full Text] [Related]
11. In vitro characteristics of poly(lactic-co-glycolic acid) microspheres incorporating gelatin particles loading basic fibroblast growth factor.
Li SH; Cai SX; Liu B; Ma KW; Wang ZP; Li XK
Acta Pharmacol Sin; 2006 Jun; 27(6):754-9. PubMed ID: 16723096
[TBL] [Abstract][Full Text] [Related]
12. Comparison of process parameters for microencapsulation of plasmid DNA in poly(D,L-lactic-co-glycolic) acid microspheres.
Hsu YY; Hao T; Hedley ML
J Drug Target; 1999 Dec; 7(4):313-23. PubMed ID: 10682910
[TBL] [Abstract][Full Text] [Related]
13. In vitro study of GDNF release from biodegradable PLGA microspheres.
Aubert-Pouëssel A; Venier-Julienne MC; Clavreul A; Sergent M; Jollivet C; Montero-Menei CN; Garcion E; Bibby DC; Menei P; Benoit JP
J Control Release; 2004 Mar; 95(3):463-75. PubMed ID: 15023458
[TBL] [Abstract][Full Text] [Related]
14. Sustained delivery of endostatin improves the efficacy of therapy in Lewis lung cancer model.
Wu J; Ding D; Ren G; Xu X; Yin X; Hu Y
J Control Release; 2009 Mar; 134(2):91-7. PubMed ID: 19084038
[TBL] [Abstract][Full Text] [Related]
15. Biodegradable PLGA microspheres as a sustained release system for a new luteinizing hormone-releasing hormone (LHRH) antagonist.
Du L; Cheng J; Chi Q; Qie J; Liu Y; Mei X
Chem Pharm Bull (Tokyo); 2006 Sep; 54(9):1259-65. PubMed ID: 16946531
[TBL] [Abstract][Full Text] [Related]
16. PEGylated TNF-related apoptosis-inducing ligand (TRAIL)-loaded sustained release PLGA microspheres for enhanced stability and antitumor activity.
Kim TH; Jiang HH; Park CW; Youn YS; Lee S; Chen X; Lee KC
J Control Release; 2011 Feb; 150(1):63-9. PubMed ID: 21062635
[TBL] [Abstract][Full Text] [Related]
17. Development of a single-dose stabilized poly(D,L-lactic-co-glycolic acid) microspheres-based vaccine against hepatitis B.
Jaganathan KS; Singh P; Prabakaran D; Mishra V; Vyas SP
J Pharm Pharmacol; 2004 Oct; 56(10):1243-50. PubMed ID: 15482638
[TBL] [Abstract][Full Text] [Related]
18. Sustained delivery of IL-1 Ra from biodegradable microspheres reduces the number of murine B16 melanoma lung metastases.
Lavi G; Voronov E; Dinarello CA; Apte RN; Cohen S
J Control Release; 2007 Nov; 123(2):123-30. PubMed ID: 17900737
[TBL] [Abstract][Full Text] [Related]
19. Stabilization and encapsulation of a staphylokinase variant (K35R) into poly(lactic-co-glycolic acid) microspheres.
He JT; Su HB; Li GP; Tao XM; Mo W; Song HY
Int J Pharm; 2006 Feb; 309(1-2):101-8. PubMed ID: 16413979
[TBL] [Abstract][Full Text] [Related]
20. Development of a single dose tetanus toxoid formulation based on polymeric microspheres: a comparative study of poly(D,L-lactic-co-glycolic acid) versus chitosan microspheres.
Jaganathan KS; Rao YU; Singh P; Prabakaran D; Gupta S; Jain A; Vyas SP
Int J Pharm; 2005 Apr; 294(1-2):23-32. PubMed ID: 15814228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
